Qingdao Baheal Medical INC. (301015) — Cash Flow Reinvestment Rate
Qingdao Baheal Medical INC. (301015) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting CN¥107.50 Million (capex CN¥107.50 Million ) from operating cash flow of CN¥230.38 Million. Check how high is Qingdao Baheal Medical INC.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qingdao Baheal Medical INC. Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Qingdao Baheal Medical INC. across 7 annual periods. Explore 301015 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year capital reinvestment analysis for Qingdao Baheal Medical INC.. For live market cap and broader valuation context, see 301015 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥589.21 Million | CN¥934.45 Million | CN¥288.93 Million | ▼ -30.1% |
| 2024 | 0.90x | CN¥734.15 Million | CN¥813.85 Million | CN¥303.99 Million | ▲ +109.0% |
| 2023 | 0.43x | CN¥345.01 Million | CN¥799.50 Million | CN¥185.49 Million | ▼ -40.7% |
| 2022 | 0.73x | CN¥222.65 Million | CN¥305.75 Million | CN¥105.32 Million | ▲ +162.4% |
| 2021 | 0.28x | CN¥50.31 Million | CN¥181.30 Million | CN¥27.49 Million | ▲ +92.5% |
| 2019 | 0.14x | CN¥6.63 Million | CN¥45.96 Million | CN¥2.95 Million | ▼ -49.2% |
| 2018 | 0.28x | CN¥15.74 Million | CN¥55.50 Million | CN¥15.74 Million | — |